Evidence map›Paper›PMID 41970876›Full record

ArticleACS omega2026

Systematic Expansion of an Ugi-Based Multicomponent Synthesis of Tetrasubstituted Imidazoles.

Robin van der Straat, Justyna Kalinowska-Tluscik, Katarzyna Kurpiewska, Alexander Dömling

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Robin van der StraatDepartment of Medicinal Chemistry, Photopharmacology and Imaging, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands.
Justyna Kalinowska-TluscikDepartment of Crystal Chemistry and Crystal Physics, Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Krakow, Poland.ORCID https://orcid.org/0000-0001-7714-1651
Katarzyna KurpiewskaDepartment of Crystal Chemistry and Crystal Physics, Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Krakow, Poland.
Alexander DömlingInnovative Chemistry Group, Czech Advanced Technology and Research Institute (CATRIN), Palacký University Olomouc, Slechtitelů 27, 77900 Olomouc, Czech Republic.ORCID https://orcid.org/0000-0002-9923-8873

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Highly substituted imidazoles are privileged scaffolds in medicinal and synthetic chemistry; however, general and modular access to densely substituted variants remains limited. Although Ugi-derived imidazole formation has been reported in isolated cases, its broader applicability has not been systematically explored. Herein, we present a comprehensive expansion and optimization of an Ugi-based one-pot synthesis enabling the preparation of tetrasubstituted imidazoles from readily accessible glyoxal derivatives. In contrast to earlier studies largely restricted to aryl glyoxals, this protocol demonstrates broad compatibility with aliphatic and aromatic glyoxals, as well as diverse amines, carboxylic acids, and isocyanides, providing full substitution control over all four positions of the imidazole ring. Key parameters governing chemoselectivity and ammonium-induced cyclization were identified, affording the target imidazoles in moderate to excellent yields. This study establishes the Ugi-imidazole transformation as a robust and diversity-oriented synthetic platform suitable for the rapid generation of medicinally relevant imidazole scaffolds.

Identifiers

PMID41970876
PMCPMC13063188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.